ORTEXORTEX News
Tracking HAWK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HA
Trader NoteHAWK

HawkEye 360 Rebounds Sharply, but Analysts Keep Cutting Targets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 20:24

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

HAWK enters the final stretch before its November 13 earnings with a striking split: the stock has bounced 14% in a week even as its Street coverage has spent months steadily marking down price targets, and a fresh MSCI index watch adds a mechanical buyer to the equation.

The analyst picture is the clearest tension in this note. Every major move over recent months has been a cut, not a raise. RBC Capital's Ken Herbert lowered his target again this week, from $28 to $21, while maintaining his Outperform rating. That follows a September cut from $33 to $28 and an earlier reduction from $40 to $33 in June. Piper Sandler initiated at Overweight with a $22 target in mid-October, and Bank of America upgraded the rating to Buy in September while simultaneously cutting the target from $34 to $23. The pattern is consistent: bulls on the name are staying bullish on direction, but continuously reducing the number they're willing to attach to it. The Street consensus mean sits at $29.10, which against a current price of $13.52 implies substantial implied upside on paper, though the target itself has been compressing rapidly and deserves that context. Valuation is stretched on some measures, with a trailing PE above 106, though the EV/EBITDA at roughly 33 times is more moderate for a high-growth defense tech company.

The short interest picture is actually improving, not worsening. Shorts have covered steadily over the past month. Estimated short shares have fallen about 13% from their recent peak near 4.8 million in late September to roughly 3.6 million now. Borrow is cheap at 0.93%, and availability has loosened markedly to 396%, meaning nearly four shares are available to borrow for every one already out on loan. That compares to a tighter patch in September when availability dipped as low as 112%. The ORTEX short score has also eased from above 53 earlier in October to 46.7 now, moving away from the bearish zone. Options positioning tells a slightly more defensive story: the put/call ratio of 1.66 remains broadly in line with its 20-day average of 1.64, so there is no unusual hedging spike, but the persistent elevation of the ratio reflects that protective demand has been a structural feature here, not a recent development.

The ownership register adds a notable entry. BlackRock Portfolio Management filed a fresh Schedule 13G on October 27, disclosing a 5.4% passive stake. Insight Holdings holds 14.5%, David G. DeWalt of NightDragon holds 9.3%, and Singapore's GIC holds 7.1%, all as passive 13G filers. No Schedule 13D activist is on the register. As always with 13D/G disclosures, stakes are as last reported around the 5% threshold and holders dropping below that level may not file again. The insider picture over the past 90 days is net negative: the CEO sold approximately $1.4 million on October 1 under a pre-arranged 10b5-1 plan, paired with a nominal option exercise. The CFO sold in mid-September without a plan on record, which carries a slightly different weight than a scheduled sale. Net insider activity over 90 days amounts to roughly minus $2.8 million across all transactions.

The index angle adds a concrete near-term calendar item. HAWK was added to the Russell 2000 in the September quarterly review, with an estimated $205 million of passive buying flowing through on September 18. ORTEX now puts the probability of a further addition to the MSCI USA Small, MSCI USA IMI, MSCI World IMI, and MSCI World Small indexes at 34% each, with the announcement due November 11 and the trade date set for November 30 if confirmed. The estimated flow across the MSCI events ranges from $18 million to $36 million depending on the index, or roughly 1 to 2.2 days of average volume. These are forecasts, not announcements. Wikipedia attention data adds a complementary signal: retail attention has spiked sharply, with the combined attention z-score reaching 4.7 as of October 21, a notable move above recent norms.

The prior two earnings prints make sobering reading for anyone already positioned for the November 13 release. In August, the stock fell nearly 8% on the day of results and lost a further 12.6% over the following week. In September's print, the next-day move was a milder 1.8% decline, but the five-day drift was still negative at 4.7%. There is no earnings reaction in the dataset that shows a positive outcome. What to watch into November 13 is whether the narrowing short interest and the potential MSCI announcement on November 11 alter the pre-earnings setup, two days before the print is a short window for that dynamic to play out.

Stocks in this article

See the live data behind this article on ORTEX.

Open HAWK on ORTEX →

How this article was generated

Generated
28 Oct 2026, 20:29
Data as of
28 Oct 2026, 20:24
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.